Twinbeech Capital LP Meridian Bioscience Inc Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $246,097 - $328,371	-10,362 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $206,929 - $279,152	10,362 New	10,362 $269,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $690,665 - $854,826	-39,557 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $686,313 - $890,032	39,557 New	39,557 $761,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $172,896 - $271,872	-9,600 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $189,696 - $286,944	9,600 New	9,600 $252,000
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $423,231 - $582,783	-26,906 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $364,307 - $710,587	26,906 New	26,906 $457,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.